Objectives: Insomnia and depressive symptoms are commonly reported by adults and have independently been found to be associated with mortality, though contrasting findings are reported. Given the high comorbidity and interrelatedness between these symptoms, we tested whether insomnia symptoms explain risk of death independent of depressive symptoms. We examined insomnia symptoms and depressive symptoms, in addition to other health and demographic covariates, as predictors of all-cause mortality. Results: After adjustment for covariates, insomnia symptoms (HR = 1.10, CI:1.07-1.13) and depressive symptoms (HR = 1.14, CI:1.12-1.16) each were associated with a greater hazard of death. When considered together, however, depressive symptoms fully accounted for the association between insomnia symptoms and mortality.
| INTRODUCTION
Sleep disturbances and other depressive symptoms are frequently reported by old adults, and both are associated with adverse mental and physical health outcomes. [1] [2] [3] Accumulating evidence also indicates that insomnia and depression are each associated with mortality, though inconsistent results have been found, and methodologies are mixed. [4] [5] [6] [7] Further, insomnia and depression are commonly comorbid and associated with poor health behaviors, which can consequently impair an individual's ability to adaptively cope and respond to their illness. [8] [9] [10] Therefore, it is important to understand whether insomnia and depressive symptoms may be associated with mortality both independently and in conjunction. This is particularly critical given the existence of validated treatments for both conditions that may positively influence mortality outcomes. The current study considers whether insomnia symptoms are associated with greater risk of mortality controlling for depressive symptoms in a nationally representative sample of adults aged 51 and older from the Health and Retirement Study (HRS). 11 
| Putative associations among aging, depression, and insomnia
Though depression is less prevalent among old adults than younger age groups, subsyndromal symptoms are common, and prognosis is often poor. 12, 13 For example, in a longitudinal study of depressed old adults, three fourths of the sample had a fluctuating or severe chronic course of symptoms, with only 23% achieving remission. 14 Further, recent studies suggest that old adults still stigmatize mental illness and mental health treatment, and thus may be undertreated leading to worse outcomes. 15 On the other hand, while approximately half of old adults report sleep complaints, studies show that most changes in sleep patterns occur by age 60, with only a slight decrease in quality of sleep thereafter. [16] [17] [18] It may be that factors such as chronic illness and functional status impact sleep more than aging alone as a putative mechanism. However, considering depressive and insomnia symptoms as risk factors for mortality among old adults in particular is of importance.
| Depression, insomnia, and mortality
Major depressive disorder and depressive symptoms have been associated with premature risk of death and mortality. 19, 20 Over a 12-year follow-up of community dwelling old adults, men with depression, for example, had a 1.9 times higher death rate than men without depression. 21 One explanation for this finding may be the high suicide completion rate among depressed men, and in particular non-Hispanic White men. 22 However, prior research has also identified depression as a risk for other causes of mortality such as heart disease. 23 Similarly, symptoms of insomnia have been associated with higher odds of mortality and premature risk of death, though the effect size is more modest than that associated with depression. 4, 20 In a communitybased sample of middle-aged adults in Norway followed for 13 to 15 years, models adjusting for demographic characteristics, lifestyle behaviors, mental health, and health variables found insomnia to be associated with a 3-fold increase in mortality. When models were run with a continuous measure of insomnia symptoms, for each increasing score value (from zero to 16), the mortality rate increased by 10%. 6 Likewise, another study found that insomnia was a strong predictor of nursing home placement and death for men, however only marginally so for women. 5 Yet nonsignificant associations have also been identified. 24 Insomnia and depression have a number of risk factors, physiological pathways, and behavioral mechanisms in common that may make the 2 conditions in combination particularly critical for mortality risk (eg, poor health behaviors, smoking, physical inactivity, obesity, HPA axis dysregulation, increased autonomic nervous system activity, and inflammation). were asked how often they have trouble with "falling asleep," "waking up during the night," "waking up too early and not being able to fall asleep again," and "you feel really rested when you wake up in the morning?" Response categories were "most of the time," "sometimes,"
and "rarely or never." To assess the greatest severity of insomnia, we defined a symptom as positive if a participant endorsed having it "most of the time" for the first 3 items and "rarely or never" for the fourth item. We then created a symptom index ranging from 0 to 4 for the number of insomnia symptoms.
Depressive symptoms

A modified 8-item version of the Center for Epidemiologic Studies
Depression Scale (CES-D) was used to assess depressive symptoms. 27 Respondents reported the extent to which in the previous week, they felt the following: depressed, everything was an effort, sleep was restless, that he or she could not get going, lonely, that he or she enjoyed life, sad, and happy. These are coded dichotomously by RAND to address differences in response categories over waves. To minimize operational confounding of this predictor with our outcome, we removed the item about restless sleep. Following others, we reversecoded the positive items and summed the remaining 7 items for a count of recent depressive symptoms ranging from 0 to 7.
28
Covariates
We controlled for demographic and health characteristics known to be associated with mortality including participant age, gender, race (categorized as white, black, and other), years of education, and history of smoking. Multimorbidity during the study (the mean of 7 possible chronic medical conditions across study waves, including high blood pressure, diabetes, cancer, lung disease, heart disease, stroke, and arthritis) was controlled in a sensitivity analysis. Other than chronic medical conditions, all demographic characteristics were taken from the current study baseline wave (2002).
| Data analysis
We used Cox proportional hazard models in SAS 9.4 to examine the association between depressive symptoms and insomnia symptoms with all-cause mortality over 12 years, modeling time to death from the baseline wave in 2002. The HRS analytic weight was applied to all models, and we accounted for the clustering and stratification of the complex sample design. Respondents who were still alive at our last study wave (2014) and those lost to follow-up were censored at their last available interview. We estimated 4 models starting with demographic and health characteristics alone predicting mortality 
| RESULTS
Sample characteristics are described in Table 1 Table 2 .
Controlling for the demographic and health characteristics in separately by gender, the findings were the same for both men and women as in the combined model.
| DISCUSSION
Rates of depressive and insomnia symptoms were similar to those found in other community-based samples of middle-aged and old adults, with 38% of our sample reporting 1 or more of 4 insomnia symptoms (America Insomnia Survey reporting 43% with at least 1 of 4 symptoms) and 12% reporting symptoms of depression above the derived clinical cut-point. 26, 28 Though small in effect relative to demographic characteristics and smoking history, both depressive and insomnia symptoms were independently associated with an increased hazard of death with each insomnia symptom increasing the hazard by 10% and each depressive symptom by 14%. The hazard associated with insomnia was similar to a community-based study in Norway, which also found a 10% increase for each increasing score value on a continuous insomnia scale. 6 This finding remained, however, after adjusting for depressive symptoms in contrast with our finding. In the current study, upon including both depressive and insomnia symptoms in the model, depressive symptoms accounted for the effect of insomnia symptoms, maintaining significance and reducing the insomnia hazard ratio to approximately 1. Depression and insomnia, though separate disorders, are highly interrelated with as many as 90% of individuals with depression reporting disturbed sleep. 10 Though insomnia can of course occur independently from depression, comorbidity is high, and our findings suggest that depression may be the key risk factor for all-cause mortality, with insomnia's effect perhaps reflected as a component of depression. In a post hoc test, we did consider our final model separately by gender, and found the same result for men and women, with depressive symptoms being a significant predictor of all-cause mortality and insomnia symptoms not maintaining significance. This is in contrast with some prior work, which only found insomnia and depressive symptoms associated with risk of death among men. 5, 21 There are several reasons why depression may be related to mortality independent of sleep. First, depression is highly related with risk for chronic illness and complications with illness that put one at increased risk for mortality. For example, depression has been associated with cardiac, cancer, and chronic obstructive pulmonary disease morbidity, exacerbations, and mortality. 23, [29] [30] [31] Additionally, though a less common cause of death, both insomnia and depression have been associated with an increased risk of suicide, with death by suicide particularly common among depressed, non-Hispanic White men. [32] [33] [34] An additional reason depression may be associated with mortality is through associated negative health behaviors such as reduced physical inactivity. Whooley et al 8 found that smoking, medication nonadherence, and in particular inactivity explained the association between depression and cardiac events. Though insomnia is a key symptom of depression and shares several physiological pathways, our study shows that depression accounted for the association of insomnia and mortality. Given the high comorbidity between the 2 sets of symptoms, it may also be that insomnia symptoms are related to mortality due to coexisting depressive symptoms. Future studies on sleep and mortality should thus account for the role of depression.
A number of empirically validated treatments for depression and insomnia exist, which may be helpful in reducing mortality risk.
For example, the American College of Physicians endorsed Cognitive Behavioral Therapy as the gold standard for initial treatment of insomnia. Pharmacotherapy with antidepressants is the most common treatment for old adults with depression and is effective when used at adequate doses for a prescribed length of time. 35 Similarly, chronic use of over-the-counter sleep medications is common among old adults (more than one third of adults aged 65 and over report using them more than 15 days a month) despite anticholinergic side-effects and warnings against these medications as listed in the Beers Criteria. 36 However, prior work has found that only about 20% to 30% of years lived with disability from depression can be avoided using these treatments. 37 
